Product Liability
Sep. 25, 2010
Access to Drug Is Restricted
The U.S. Food and Drug Administration restricted access to Avandia and overseas regulators recommended suspension of GlaxoSmithKline's marketing efforts for the diabetes drug in Europe.
Daily Journal Staff Writer
The U.S. Food and Drug Administration restricted access to Avandia and overseas regulators recommended suspension of GlaxoSmithKline's marketing efforts for the diabetes drug in Europe on Thursday.
Thousands of people have sued the London-based drugmaker over Avandia after heart attacks, strokes and other side effects.
Because of new data showing high cardiovascular...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In